IGC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
IGC Pharma Inc is not a good buy for a beginner, long-term investor at this moment. The technical indicators are bearish, the financial performance shows declining revenue, and there are no positive catalysts or strong trading signals to support a buy decision. Additionally, options data reflects a highly bearish sentiment.
The MACD is below 0 and negatively contracting, RSI is neutral at 40.546, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 0.26, with key support at 0.246 and resistance at 0.273. Overall, the technical indicators suggest a bearish trend.
NULL identified. No recent news or significant insider/hedge fund activity to act as a positive catalyst.
Declining revenue (-53.64% YoY) and a bearish technical setup. Options data also reflects bearish sentiment. Stock trend analysis indicates a high probability of negative returns over the next week and month.
In Q2 2026, revenue dropped by -53.64% YoY to $191,000. Net income improved slightly but remains negative at -$1,821,000. EPS remained unchanged at -0.02. Gross margin increased to 51.83%, up 7.84% YoY. Overall, the financial performance shows declining growth with no strong improvement in profitability.
No analyst ratings or price target changes available for IGC Pharma Inc.
